Rv3083 - p.His168Pro
Drug resistance types
0 Sensitive
0 RR-TB
0 HR-TB
11 MDR-TB
14 Pre-XDR-TB
6 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.1 | 21 |
| lineage4.3.4.1 | 3 |
| lineage2.2.1;lineage3 | 1 |
| lineage2.2.1.1 | 2 |
| lineage4.2.1.1;lineage4.3.3 | 1 |
| lineage4.2.1.1 | 3 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 31 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR18715484 | Pre-XDR-TB | lineage2.2.1 | None | SRR3742659 | Pre-XDR-TB | lineage2.2.1 | None | ERR2516699 | Pre-XDR-TB | lineage4.3.4.1 | pe | SRR5153232 | Pre-XDR-TB | lineage2.2.1 | None | ERR4799663 | Pre-XDR-TB | lineage2.2.1;lineage3 | in | ERR5864652 | MDR-TB | lineage2.2.1 | None | ERR5866032 | Pre-XDR-TB | lineage2.2.1 | None | ERR5865260 | Pre-XDR-TB | lineage2.2.1 | None | ERR5864650 | MDR-TB | lineage2.2.1 | None | SRR1368341 | Pre-XDR-TB | lineage2.2.1.1 | None | SRR1368340 | Pre-XDR-TB | lineage2.2.1 | None | SRR3742658 | Pre-XDR-TB | lineage2.2.1.1 | None | SRR3742661 | XDR-TB | lineage2.2.1 | None | SRR28394215 | Pre-XDR-TB | lineage4.3.4.1 | None | SRR23862079 | Pre-XDR-TB | lineage2.2.1 | None | SRR13232729 | MDR-TB | lineage4.2.1.1;lineage4.3.3 | None | SRR3742662 | XDR-TB | lineage2.2.1 | None | ERR5864651 | MDR-TB | lineage2.2.1 | None | ERR11044615 | Pre-XDR-TB | lineage2.2.1 | None | ERR5864655 | MDR-TB | lineage2.2.1 | None | SRR28393377 | MDR-TB | lineage4.3.4.1 | None | ERR5917752 | MDR-TB | lineage4.2.1.1 | by | ERR8665965 | MDR-TB | lineage4.2.1.1 | None | ERR8665966 | MDR-TB | lineage4.2.1.1 | None | SRR3742660 | XDR-TB | lineage2.2.1 | None | SRR7517822 | Pre-XDR-TB | lineage2.2.1 | ch | ERR5864653 | MDR-TB | lineage2.2.1 | None | SRR1368339 | XDR-TB | lineage2.2.1 | None | ERR5864654 | MDR-TB | lineage2.2.1 | None | SRR1368338 | XDR-TB | lineage2.2.1 | None | SRR1368337 | XDR-TB | lineage2.2.1 | None |
|---|
